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Research Paper
Depression in patients with chronic pain attending
a specialisedpain treatment centre: prevalenceand
impact on health care costs
Lauren Raynera,*, Matthew Hotopfa, Hristina Petkovab, Faith Matchama, Anna Simpsona, Lance M. McCrackenc,d
Abstract
This cross-sectional study aimed to determine the prevalence and impact of depression on health care costs in patients with
complex chronic pain. The sample included 1204 patients attending a tertiary pain management service for people with chronic
disabling pain, unresponsive to medical treatment. As part of routine care, patients completed a web-based questionnaire
assessing mental and physical health, functioning, and service use in the preceding 3 months. Depression was assessed using the
9-item Patient Health Questionnaire. Self-report health care utilisation was measured across 4 domains: general practitioner
contacts, contacts with secondary/tertiary care doctors, accident and emergency department visits, and days hospitalised. The
participation rate was 89%. Seven hundred and thirty-two patients (60.8%; 95%CI 58.0-63.6) met criteria for probable depression,
and 407 (33.8%)met the threshold for severe depression. Patients with depression weremore likely to be unable to work because of
ill health and reported greater work absence, greater pain-related interference with functioning, lower pain acceptance, and more
generalised pain. Mean total health care costs per 3-month period were £731 (95% CI £646-£817) for patients with depression,
compared with £448 (95% CI £366-£530) for patients without depression. A positive association between severe depression and
total health care costs persisted after controlling for key demographic, functional, and clinical covariates using multiple linear
regression models. These findings reveal the extent, severity, and impact of depression in patients with chronic pain and make
evident a need for action. Effective treatment of depression may improve patient health and functioning and reduce the burden of
chronic pain on health care services.
Keywords: Depression, Chronic pain, Health care utilization, Health care costs
1. Background
Chronic pain and depression are each prevalent and often co-
occur.5 Although the underlying mechanism of the interaction
between pain and depression is not fully understood, their
coexistence has been shown to incur additive adverse effects on
patient outcomes, including poorer functioning and reduced
response to treatment.2,36 The systematic review of Bair et al.5
revealed wide variation in estimates of the prevalence of
depression in patients with chronic pain. Estimates ranged from
4.7% to 22% in population-based studies and from 5.9% to 46%
in primary care studies. Variability in estimates was particularly
striking in studies of specialist pain populations (1.5%-100%).
Most of these studies, however, were conducted in the 1980s
and included fewer than 100 participants. More recent studies of
depression in specialist pain settings have yielded prevalence
estimates ranging from 12.1% to 72%, but sample sizes remain
small.20,27,28,33
Chronic pain poses an enormous economic burden on society
both in terms of medical care and lost productivity. A National
Institutes of Health report in 2011 estimated the total annual
incremental cost of health care due to pain in the United States at
$261-$300 billion. The total cost to society, including indirect
costs of pain due to lower economic productivity, was estimated
at $560-$635 billion—greater than the cost of heart disease,
cancer, or diabetes.21 Given the magnitude of these costs,
surprisingly, few studies have examined the factors associated
with health care utilisation in people with chronic pain. Blyth et al.8
found that a high level of pain-related interference was associated
with a greater number of general practitioner (GP) and emergency
department visits and more frequent hospitalisation, in the
general population. Azevedo et al.4 identified depressed mood
and pain-related disability as the main drivers of increased
medical consultations, and Andersson et al.1 found that people
with chronic pain and depressive symptoms made more
physician visits than those with pain alone. These population-
based studies indicate that pain interference and depressionmay
predict health care use, but there remains a dearth of data from
more complex, multiproblem, specialist pain populations.
If depression modifies the relationship between chronic pain
and health care utilisation, there may be opportunities to reduce
the burden of chronic pain on both the individual and society,
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through improved detection and treatment of the disorder in this
context. Up to date evidence on the prevalence and impact of
depression in specialist pain services is therefore necessary to
determine the need for increased investment in mental health
resources for this population. The aims of this study were (1) to
determine the prevalence of depression in a specialist pain
population and (2) to describe the impact of depression on health
care utilisation and costs.
2. Methods
2.1. Participants
The study sampling frame was all patients attending an initial
assessment consultation at the INPUT pain unit at Guy’s and St
Thomas’ NHS Foundation Trust in central London, United
Kingdom, between February 2013 and June 2015. The INPUT
pain unit is a specialty interdisciplinary pain management
service that provides residential, outpatient, and individual
treatment for patients with chronic pain. Generally, the referral
population for the service includes people with chronic pain
(typically greater than 9 months), and disability, who have
sought previous primary care and hospital care, such as pain
clinic, orthopedics, or rheumatology services, for their pain
without satisfactory resolution. Most referrals are from the south
east of England. The INPUT pain unit is a typical U.K. tertiary
care service.
2.2. Procedure
Data were collected as part of routine care using the IMPARTS
(Integrating Mental and Physical healthcare: Research Training
and Services) web-based screening interface.29 IMPARTS is
a multifaceted service development package designed to
improve integration of mental and physical health care. It does
this through (1) routine measurement of mental and physical
patient-reported outcomes, with real-time feedback and decision
support through the electronic patient record; (2) development of
mental health referral pathways for individuals with identified
mental health needs; (3) training staff in core mental health skills;
and (4) development of self-help materials specific to the
condition in question. Further information about IMPARTS has
been reported elsewhere.29 The INPUT pain unit implemented
IMPARTS in February 2013 to facilitate systematic assessment of
depression alongside other outcomes pertinent to the chronic
pain population. Patients were approached to participate in
screening at their first visit to INPUT, which is an assessment
consultation to determine their suitability for the treatments
provided. Consecutive patients attending the assessment clinic
were invited by reception staff to complete a questionnaire on
a touchscreen e-tablet in the waiting room, before their
consultation. IMPARTS establishes routine outcome measure-
ment as a service development rather than as a research project.
Therefore, formal consent was not required, but patients were
informed and given information sheet explaining that completion
of the questionnaire was voluntary and that responses would be
confidential and only used for audit or research if fully
anonymised. On completion of the questionnaire, patients’
screening results immediately populated their electronic patient
record, ready for the clinical team to review.
IMPARTS has research ethics approval from the National
Research Ethics Service Research Database Committee (NRES,
Ref: 12/SC/0422), which permits the use of de-identified data
collected through IMPARTS for research purposes, with the
added safeguard that each project was approved by a patient-led
research oversight committee.
2.3. Clinical outcome measures
Measures were selected for inclusion in the IMPARTS question-
naire in collaboration with the INPUT clinical team, based on
appraisal of the existing scientific literature. The questionnaire
was necessarily brief so that it could be completed in the course
of routine care, with minimal impact on staff and patients’ time.
Depression was assessed using the 9-item Patient Health
Questionnaire (PHQ-9),35 which has been validated in patients
with a broad range of physical health problems, including chronic
pain.9 A meta-analysis of 113 studies examining the diagnostic
accuracy of depression case-finding tools in chronic illness
showed that the PHQ-9 had high sensitivity (0.84; CI 0.69-0.91)
and specificity (0.88; CI 0.83-0.91) compared with other
commonly used screening tools such as the Hospital Anxiety
and Depression Scale and the General Health Questionnaire
12.25 Choi et al.9 found that the PHQ-9 was among the best-
performing tools (area under the curve, 0.796 [SE, 0.022]) in their
comparison of case-finding instruments for depression in
patients with chronic spinal pain.
Criteria for probable major depressive disorder (MDD) were
met if the patient reported lowmood or loss of interest and at least
5 of 9 symptoms in total, for more than half the days in the last 2
weeks. Item 9 (suicidal thoughts) counted towards the diagnosis
of MDD if present at all. Severe depression was defined as MDD
caseness with PHQ-9 score 20 to 27, moderate depression was
defined as MDD caseness with PHQ-9 score 15 to 19, and mild
depressionwas defined asMDDcasenesswith PHQ-9 score,15.
Suicidal ideationwas assessedby item9 of thePHQ-9 anddefined
as having “thoughts that you would be better off dead or of hurting
yourself in some way” for more than half the days in the previous 2
weeks. Pain acceptancewasmeasured using the 8-item version of
theChronicPain AcceptanceQuestionnaire (CPAQ).24 TheCPAQ-
8 measures the extent to which the patient is able to experience
pain without struggling to control or avoid it. It has a 2-factor
structure: pain willingness (disengagement from efforts to control
or avoid pain) and activity engagement (doing valued activities
despite the presence of pain). Level of pain acceptance is
measured on a 0 to 6 rating scale. Pain willingness, activity
engagement, and total pain acceptance scores are calculated by
summing the responses in eachdomain. Psychometric evaluations
of the short-formCPAQ-8 have shown the same factor structure as
the original 20-item version, with good reliability and validity.15,31
Low pain acceptance has been found to be strongly associated
with depression, independent of pain intensity.22,38
2.4. Resource use and cost
Self-report resource use data were collected as part of the
IMPARTS questionnaire. Four domains of health care service use
for pain in the preceding 3 months were measured: (1) GP
contacts, (2) contacts with other doctors (eg, secondary/tertiary
care), (3) accident and emergency department (A&E) visits, and
(4) days hospitalised. For example, patients were asked “How
many times have you seen your GP in the past 3 months for your
pain?” To monetarily value patient-reported health care utilisa-
tion, each service was assigned a unit cost. Health care costs
were calculated by multiplying each resource use item by the unit
cost. All unit costs, in British Pound Sterling, were from the
financial year 2013 to 2014 and were obtained from sources
detailed in Table 1.
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Pain interference is associated with depression and has been
shown to predict health care utilisation in population-based
studies.5 We assessed pain interference using the Brief Pain
Inventory (BPI).13 The pain interference dimension of the BPI
comprises 7 items measuring the degree to which pain interferes
with functioning in the following domains: general activity, mood,
walking ability, normal work, relations with other persons, sleep,
and enjoyment of life. Level of interference is measured using
a rating scale from 0 (no interference) to 10 (complete
interference), and the mean score denotes the total level of pain
interference. The BPI has been widely used and validated as
a measure of pain interference in daily functioning.37 Research
indicates that pain interference is a powerful independent
predictor of depression12 and may also be a driver of higher
health service costs.8
Pain relief provided from treatments or medications was also
measured by the BPI. Question 7 asks the patient to select the
percentage that best indicates the extent of relief, on a 10-point
scale from 0% to 100%.13 Additionally, patients were asked
about the duration, location, and extent of their pain and whether
they experienced generalised pain (yes/no). Smoking status and
occupational functioning were also assessed.
2.5. Data analysis
Prevalence and severity of probable depression were
expressed as the percentage of cases determined by the
PHQ-9, with 95% CI. The sociodemographic and clinical
characteristics of patients with and without depression were
compared using the x2 test for categorical data and the
Mann–Whitney U test for continuous data that were not
normally distributed. For ordinal data, test for trend was
calculated using logistic regression, with P values derived from
the Wald test. Mean costs were compared using the Student
t-test. Inferences about average cost differences should always
be based on a comparison of the arithmetic mean, even though
cost data are often skewed.6
Multivariate analysis of the impact of depression on health care
costs was conducted using multiple linear regression models
(ordinary least squares). We expected health care costs to vary by
depression severity; therefore, for the regression analysis, we
categorised depression into 4 categories (none/mild/moderate/
severe). The purpose of the regression analysis was not to find the
best model to explain variability in health care costs but rather to
test the hypothesis that depression is predictive of cost whilst
controlling for potential confounders. Potential adjustment
variables were selected based on established associations
identified in the literature and statistical relationships with
outcome and exposure variables detected in the data. Auto-
mated selection procedures and model fitting based solely on
significance testing may result in inappropriate inclusions and
exclusions. Although there is no agreed optimal strategy for
modelling, confounder identification should be based on a priori
knowledge about associations and causal pathways (research
evidence and expert judgement) in addition to statistical
information.18 Given that there is uncertainty in the literature
regarding the causal network linking depression, health care
costs, and potential confounders such as pain severity, we
computed 4models with varying levels of adjustment, to examine
how selection of adjustment variables impacted the relationship
between depression and health care costs: model 1, unadjusted;
model 2, adjusted for age and sex; model 3, additionally adjusted
for occupational status; model 4, additionally adjusted for pain
interference, pain acceptance, and generalised pain. Health care
costs were skewed to the right; therefore, nonparametric
bootstrapping (1000 replications) was used to estimate bias-
corrected and accelerated confidence intervals around cost
differences. All statistical analyses were performed using Stata 11
software.
3. Results
During the study period (February 2013 to June 2015), 1352
patients attended an assessment consultation at the INPUT pain
unit, and of these, 1204 (89%) completed the IMPARTS
questionnaire. Data on the reasons for nonparticipation were
not recorded, but clinic staff reported that the most common
reasons were patients arriving late and an inadequate number of
e-tablets being available.
3.1. Sample characteristics
Two-thirds of the sample were women, and the median age was
47 (interquartile range, 38-53). Just over half of the sample
(52.8%) reported being unable to work for health reasons,
whereas 22% was currently employed. The median duration of
pain was 7 years. Lower back pain was themost frequent primary
complaint, and 88% of the sample reported experiencing
generalised pain (Table 2).
3.2. Prevalence of depression
According to the PHQ-9, 732/1204 patients (60.8%; CI 58.0-
63.6) met criteria for probable MDD. Sixty-nine patients (5.7%)
met the threshold for mild MDD, 256 (21.3%) met the threshold
for moderate MDD, and 407 (33.8%) met the threshold for severe
MDD. One hundred eighty-three of 1204 patients (15.2%)
reported suicidal thoughts.
3.3. Demographic and clinical characteristics of depressed
vs nondepressed patients
Table 2 compares the demographic and clinical characteristics of
chronic pain patients with and without depression. There was no
difference in gender, but a small statistically significant difference
in median age between depressed and nondepressed patients
(46 vs 47). More patients with depression reported being unable
to work because of ill health, and of those in employment,
Table 1
Unit costs and sources for patient-reported health care service use.
Health care service Unit Unit cost Source
General practice Cost per 11.7-min consultation (direct and qualification costs) £46.00 Curtis 2014: Unit Costs of Health and Social Care11
Secondary/tertiary care Mean cost per outpatient pain management consultation £135.00 NHS Reference Costs 2013-201414
Accident and emergency Mean cost per accident and emergency department attendance £124.00 NHS Reference Costs 2013-201414
Inpatient treatment Mean cost per day hospitalised (regular day or night admission) £400.00 NHS Reference Costs 2013-201414
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depressed patients were more likely to have taken .21 days of
sickness absence in the past year. The extent of pain (number of
regions affected) was greater for patients with depression.
Patients with depression were also more likely to report having
generalised pain. Depressed patients had reduced pain
acceptance, scoring lower overall on the CPAQ-8, and also on
the pain willingness and activity engagement subscales. Patients
with depression experienced greater pain interference that those
without depression and were also more likely to smoke.
Depressed and nondepressed patients did not differ regarding
Table 2
Sociodemographic and health-related characteristics of nondepressed vs depressed patients.
Characteristics All, n 5 1204 Depressed, n 5 732 Nondepressed, n 5 472 P
Age (y), median (IQR) 47 (38-53) 46 (38-53) 47 (38-55) z 5 2.39, P 5 0.017
Sex, frequency (%)
Female 802 (66.6) 475 (64.9) 327 (69.3) x2 5 2.49, P 5 0.115
Male 402 (33.4) 257 (35.1) 145 (30.7)
Occupational status, frequency (%)
Employed 270 (22.4) 118 (16.1) 152 (32.2) x2 5 79.80, P 5 0.001
Unemployed 120 (10.0) 69 (9.4) 51 (10.8)
Retired/homemaker/student 178 (14.8) 86 (11.8) 92 (19.5)
Unable to work because of ill health 636 (52.8) 459 (62.7) 177 (37.5)
Sickness absence* (days off due to illness in past
year), n 5 283, frequency (%)
0 26 (9.2) 8 (6.4) 18 (11.5) Test for trend: z 5 3.36, P 5 0.001‡
1-5 45 (15.9) 11 (8.7) 34 (21.7)
6-10 34 (12.0) 16 (12.7) 18 (11.5)
11-20 46 (16.3) 20 (15.9) 26 (16.6)
21 or more 132 (46.6) 71 (56.4) 61 (38.9)
Retired early for health reasons, n 5 117,
frequency (%)
Yes 74 (63.3) 37 (72.6) 37 (56.1) x2 5 3.36, P 5 0.067
Duration of pain (y), median IQR 7 (4-15) 7 (4-15) 7 (4-15) z 5 20.70, P 5 0.484
Location of pain (region where most pain
experienced), frequency (%)
Head, face, or mouth 42 (3.5) 26 (3.6) 16 (3.4) x2 5 1.89, P 5 0.984
Neck region 74 (6.2) 43 (5.8) 31 (6.6)
Upper shoulder or upper limbs 108 (9.0) 60 (8.2) 48 (10.2)
Chest region 17 (1.4) 10 (1.4) 7 (1.5)
Abdominal region 37 (3.1) 23 (3.1) 14 (3.0)
Lower back, lumbar spine, sacrum, and
coccyx
645 (53.6) 399 (54.5) 246 (52.1)
Lower limbs 229 (19.0) 139 (19.0) 90 (19.0)
Pelvic region 41 (3.4) 25 (3.4) 16 (3.4)
Anal or genital region 11 (0.9) 7 (1.0) 4 (0.9)
Extent of pain (number of regions affected),
frequency (%)
1-3 462 (38.4) 230 (31.4) 232 (49.2) Test for trend: z 5 6.44, P , 0.001‡
4-6 496 (41.2) 321 (43.9) 175 (37.1)
7-9 246 (20.4) 181 (24.7) 65 (13.8)
Generalised pain, frequency (%)
Yes 1056 (87.7) 663 (90.6) 393 (83.2) x2 5 14.23, P , 0.001
Pain acceptance (CPAQ total)
Higher score 5 greater acceptance, median
(IQR)
15 (8-20) 12 (7-18) 19 (14-23) z 5 12.92, P , 0.001
Pain willingness subscale
Higher score 5 greater pain willingness,
median (IQR)
6 (3-9) 5 (2-8) 7 (4-10) z 5 8.36, P , 0.001
Activity engagement subscale
Higher score5 greater activity engagement,
median IQR
8 (4-12) 6 (3-10) 11 (7-14) z 5 8.36, P , 0.001
Pain interference (BPI score)
Higher score 5 greater pain interference,
median (IQR)
8.0 (6.9-9.0) 8.6 (7.6-9.3) 7.1 (6.0-8.1) z 5214.07, P , 0.001
Relief received from medication
Higher score 5 greater relief, median (IQR) 30 (20-50) 30 (20-50) 40 (20-50) z 521.27, P 5 0.203
Smoking status, n 5 1083,† frequency (%)
Currently smoking 311 (28.7) 216 (33.1) 95 (22.1) x2 5 15.28, P , 0.001
* Only patients who reported being in employment or education were asked about sickness absence; therefore, the denominator is smaller.
† The smoking question was added to the IMPARTS questionnaire after the other measures; therefore, the denominator is smaller.
‡ P value derived from the Wald test.
BPI, Brief Pain Inventory; CPAQ, Chronic Pain Acceptance Questionnaire; IQR, interquartile range.
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the duration of pain or the extent of relief received from
medication.
3.4. Descriptive analyses: depression and health care costs
Table 3 compares resource use and costs per 3 months for
patients with and without depression. Compared with those
without depression, a larger proportion of depressed patients
visited a GP for their pain in the 3 months preceding IMPARTS
assessment (87% vs 77%). Depressed patients were also more
likely to have contact with other doctors (71% vs 67%), attend
A&E (18% vs 13%), and be admitted to hospital (13% vs 7%).
Mean costs per patient were also higher for patients with
depression than for those patients without depression. A
statistically significant cost difference was observed in every
health care domain, but the difference was greatest for hospital
admissions, where expenditure for depressed patients was more
than twice that for nondepressed patients (£266; CI £147-£384
vs £101; CI £38-£164). Total health care costs per participant
over 3 months were estimated at £731 (CI £603-£861) for
patients with depression, compared with £448 (CI £366-530) for
patients without depression (P 5 0.001).
3.5. Multivariate analysis
Table 4 presents the results of the multiple regression analyses
by health care domain, with 3-month costs as the dependent
variable. It shows that moderate and severe depression had
a significant impact on total health care costs per 3 months,
which was attenuated but not eliminated with adjustment for
potential confounders. In model 2, adjusted for age and
gender, the relationship between depression and health care
costs remained virtually unaltered, with only a marginal de-
crease in mean cost differences across health care domains. In
model 3, additional adjustment for occupational status resulted
in further, but again modest, reductions in mean cost differ-
ences. The association between moderate/severe depression
and health care costs persisted with the addition of pain
variables (generalised pain, pain acceptance, and pain in-
terference) in model 4, although a more pronounced attenu-
ation of the effect was observed, particularly for “hospital
admission” and “other doctor” costs. Severe depression
increased 3-month total health care costs by £248 (CI £43-
£507). Moderate depression increased total health care costs
by £134 (CI £-52-£364), although the effect did not reach
statistical significance. No effect was observed for mild
depression. Among domain-specific costs, depression had
a significant impact on GP costs (P , 0.001), with moderate
and severe depression increasing 3-month costs by £48 (CI
£21-£78) and £43 (CI £20-£66), respectively. Severe
depression also increased costs for A&E attendance, hospital
admission, and other doctor contacts, although these effects
were not statistically significant.
4. Discussion
This study documents a high prevalence of depression in people
with chronic pain, 60.8%, based on a standard self-report
measure in a large specialty care sample. The symptoms of
depression reported in this group reflected a high severity, with
55.6% of those meeting criteria reporting a severe level of
symptoms or 33.8% of the total sample. Overall, patients who
met criteria for depression were more likely not to work because
of ill health and reported greater work absence, more generalized
pain, greater pain-related interference with functioning, lower
pain acceptance, and greater health care use and costs, relative
to those who did not meet these criteria. These patients were also
more likely to smoke.
Depression was linked to greater health care use in each of the
services assessed, including GP visits, other doctor visits, A&E
visits, and hospital admissions. The greater use of A&E and
hospital admission was particularly notable, proportionally 31%
and 44% greater, respectively. In multivariate analyses, which
included key covariates, the association between depression and
higher health service costs persisted for patients with more
severe symptomatology. In the fully adjusted model, we found
significantly higher total health care costs for patients with severe
depression. General practitioner costs also remained significantly
higher for patients with moderate-to-severe depression. The
persistence of the effect indicates that the association between
depression and health care costs is independent of pain severity.
The range of available prevalence estimates suggests that
depression is a substantial problem among patients with chronic
pain. This study updates and underscores this finding. The
prevalence of depression observed here is somewhat higher than
the average for other recent studies of this same type of
population, those seeking specialty treatment for chronic
pain.20,27,28,33 Methodological differences—most notably the
use of different case-finding tools—may have led to the apparent
variation or there may be another explanation, such as a local
factor relating to the region or service where this study was
conducted. For example, the INPUT pain unit is a tertiary care
service. Patients referred here have previously sought primary
and secondary care for their pain without satisfactory resolution
and thus may be at increased risk of depression. Preferential
referral of patients presenting with psychological distress may
also partially account for the high prevalence of depression in this
patient group. Our single centre design limits the extent to which
we can make general statements regarding the study findings.
Health care utilisation and depression might be higher in this
Table 3
Association between depression and 3-month health care utilisation/costs (£).
Health care service use in past 3 mo Proportion of patients using health
care service
Costs
Depressed Nondepressed Depressed Nondepressed P
Frequency (%) Frequency (%) Mean SD Mean SD
General practitioner contacts 635 (86.8) 363 (76.9) 166.19 180.52 108.47 113.00 ,0.001
Other doctor contacts 519 (70.9) 318 (67.4) 258.57 367.29 214.80 252.68 0.024
Accident and emergency department attendance 134 (18.3) 60 (12.7) 40.99 111.59 25.01 86.33 0.008
Hospital admission 92 (12.6) 33 (7.0) 266.12 1629.75 101.06 695.99 0.038
Total 731.72 1775.21 448.09 902.30 0.001
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sample than in other pain populations because both may predict
entry to the INPUT unit. Even those classified as nondepressed
may have had relatively high depressive symptomatology,
resulting in a smaller association between depression and health
care costs than would be observed in populations with greater
variability. Further study is needed to test the reliability of our
results and their applicability to different settings.
A notable limitation of this study is the potential for mis-
classification of exposure. The PHQ-9 is a self-report screening
tool that has been shown to have high sensitivity and specificity
compared with other case-finding tools.25 It nonetheless lacks
the depth and diagnostic validity of the gold standard clinical
interview andwill both miss cases and identify cases erroneously.
The PHQ-9 uses the 9 core DSM-V criteria for depression but
does not take account of exclusionary criteria that should
preclude diagnosis—ie, that symptoms should not be caused
by substance misuse or a general medical condition nor be better
accounted for by bereavement. Furthermore, several symptoms
assessed by the PHQ-9, such as difficulty concentrating and
sleep disturbance,3 may be attributable to depression or pain. It is
therefore possible that some study participants reporting these
symptoms were misclassified as depressed, resulting in an
inflated estimate of depression prevalence and dilution of the true
strength of the association between depression and health care
costs. Additionally, it should be noted that temporally, health care
utilisation preceded measurement of the PHQ-9. In assessing
depression subsequent to health care spending, our analysis
assumes that depression is a relatively stable behaviour pattern
that also preceded the health care. Yet, it is possible that some
patients who screened positive for depression on the PHQ-9
were not depressed in the previous 3 months, and some who
screened negative may have only recently remitted. Neverthe-
less, the impact of depression instability on our results is likely to
be small,26 and we believe it is plausible that depressed patients
with high health care costs in the preceding 3 months would
continue to have high costs in subsequent months.
Table 4
Multiple regression analysis with 3-month difference in health care costs (£) as the dependent variable.
Health care costs (£)
General practitioner
contacts
Other doctors Accident and emergency
department attendance
Hospital admission Total
b(95% CI) b(95% CI) b(95% CI) b(95% CI) b(95% CI)
Model 1†
Depression (ref: not
depressed)
Mild 25.1 (226.6 to 23.9) 232.8 (282.4 to 31.7) 5.5 (213.9 to 39.0) 219.9 (2108.5 to 202.9) 251.1 (2190.6 to 281.1)
Moderate 61.0 (36.2 to 95.5)a 7.7 (227.8 to 52.8) 12.8 (20.5 to 33.4) 128.6 (20.03 to 370.0) 211.4 (61.4 to 473.3)c
Severe 66.4 (48.3 to 88.5)a 79.4 (37.5 to 135.6)b 19.8 (8.1 to 33.8)b 219.3 (73.5 to 494.7)c 386.1 (210.3 to 656.2)b
Test for trend, P ,0.001a 0.001b 0.002b 0.017c ,0.001a
R2 (adjusted) 0.039 0.012 0.005 0.003 0.011
N‡ 1203 1204 1203 1203 1201
Model 2*
Depression (ref: not
depressed)
Mild 24.5 (227.1 to 25.5) 233.0 (283.5 to 29.7) 4.6 (215.3 to 35.5) 226.3 (2118.9 to 181.7) 258.3 (2197.0 to 263.4)
Moderate 60.0 (34.6 to 94.2)a 5.8 (229.2 to 50.0) 11.3 (22.3 to 30.7) 116.3 (214.0 to 362.1) 194.3 (39.4 to 442.6)c
Severe 65.7 (46.9 to 87.9)a 77.0 (33.9 to 132.3)b 17.2 (5.7 to 31.2)b 199.1 (60.2 to 433.0)c 359.9 (194.4 to 605.4)b
Test for trend, P ,0.001a 0.002b 0.006b 0.017c ,0.001a
R2 (adjusted) 0.042 0.013 0.019 0.008 0.020
N‡ 1203 1204 1203 1203 1201
Model 3§
Depression (ref: not
depressed)
Mild 29.7 (233.4 to 18.2) 235.5 (287.2 to 28.7) 3.2 (216.6 to 34.3) 258.7 (2166.4 to 115.4) 299.8 (2253.0 to 179.7)
Moderate 54.7 (29.1 to 87.0)a 2.2 (234.0 to 50.6) 11.4 (22.6 to 29.6) 96.4 (235.1 to 325.6) 165.5 (2.3 to 385.7)c
Severe 56.6 (36.0 to 78.6)a 74.0 (30.6 to 128.2) 16.2 (3.6 to 30.8)c 164.1 (15.2 to 390.0)c 312.0 (121.8 to 555.8)b
Test for trend, P ,0.001a 0.003b 0.015c 0.052 0.002b
R2 (adjusted) 0.048 0.012 0.020 0.009 0.021
N‡ 1203 1204 1203 1203 1201
Model 4‖
Depression (ref: not
depressed)
Mild 215.8 (241.6 to 13.6) 249.8 (2101.3 to 19.6) 1.0 (219.9 to 33.4) 268.4 (2183.4 to 115.5) 2132.1 (2292.9 to 135.3)
Moderate 47.9 (20.7 to 78.1)b 217.3 (257.5 to 27.9) 8.7 (26.7 to 27.1) 94.1 (264.0 to 359.0) 134.3 (252.4 to 363.6)
Severe 43.1 (20.1 to 66.5)a 36.0 (210.4 to 82.9) 11.0 (26.6 to 25.7) 157.4 (210.8 to 404.0) 248.6 (43.4 to 507.7)c
Test for trend, P ,0.001a 0.168 0.153 0.103 0.024c
R2 (adjusted) 0.053 0.018 0.022 0.007 0.021
N‡ 1203 1204 1203 1203 1201
aP , 0.001; bP , 0.01; cP , 0.05.
* Model 2—adjusted for age and gender.
† Model 1—unadjusted.
‡ Three patients provided invalid responses to questions about health care utilisation. These were changed to “missing,” hence the variability in N across health care service domains.
§ Model 3—adjusted for age, gender, and occupational status.
‖ Model 4—adjusted for age, gender, occupational status, generalised pain, pain interference (Brief Pain Inventory), pain acceptance (Chronic Pain Acceptance Questionnaire 8).
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The possibility of inaccurate recall of health care utilisation is
another limitation. In this analysis, health care utilisation, and
therefore health care costs, relied on information collected from
patients. Self-report is an efficient, widely used method of
assessing service use, recognised for its simplicity and cost
efficiency compared with retrieval of medical records.34 These
attributes make self-report particularly suitable for studies with
large samples and those assessing several domains of health
service use. Studies in general medical and mental health
populations have shown good levels of reliability and high
congruency rates between self-report and medical records for
recall periods of up to 12 months.7,17 Nevertheless, the most
accurate measure of service use is obtained by using multiple
sources, and our reliance on a single method of data collection is
a limitation that we acknowledge. Furthermore, Rozario et al.32
found that depression was a marginally significant factor in
predicting lower congruence between self-report and medical
record data, and there is some evidence that severely depressed
patients may overreport health care utilisation.30 It is therefore
possible that recall bias may have inflated the association between
severe depression and health care costs observed in this study.
A limited number of variables were assessed in this study,
necessarily so, as the routine assessment process needed to be
short. Potentially, there are other confounding variables that, if
available, could have led to differing conclusions about associ-
ated factors, impacts, service use, and costs. For example, illness
perceptions have been shown to be associated with both
depression10 and health care utilisation, with illness worry, a long
timeline perspective, and belief in serious consequences,
predicting high service use.16 Differences in underlying comor-
bidity and ongoing treatment of depression are also possible
confounders. Patients with chronic conditions requiring regular
medical intervention and those being treated for depression are
likely to see their GP more frequently. Although patients were
asked to report specifically on health service use for pain, some
may have found it difficult to disentangle the primary reason for
their consultation, and this may have led to an overestimation of
the association between depression and GP visits in our sample.
It would also have been helpful to include sociodemographic
information such as ethnicity and social deprivation in the
analysis. However, a high level of data errors and omissions from
clinical records meant that these data were not consistently
accurate or available.
We adopted a narrow costing approach, focusing on the
impact of comorbid depression on health care service costs.
Exploration of indirect costs due to reduced economic pro-
ductivity would be needed to estimate the cost impact from
a societal perspective. Finally, we have not approached the
question of mechanism here. Although depression is associated
with greater impacts of pain, essentially poorer health and
functioning, and greater health care costs, we can only speculate
about the processes that underlie these links. Our study was
cross-sectional so cannot identify the order of events or causal
relations between variables.
Elsewhere, we have proposed the application of an integrated
theoretical model23 that combines core behavioural, cognitive, and
emotional processes that likely underlie both common health
problems, such as pain and depression, and ostensibly varied
therapeutic approaches. Perhaps, this kind of approach, which
sees pain and depression as rooted in the same psychological and
biological processes, rather than as separate disorders that co-
occur, could help untangle the problems examined here. Such
processesmight includegeneral psychological avoidanceorwhat is
known as “experiential avoidance” and failures in goal-directed
engagement, both components of what is referred to as
psychological inflexibility.23 A clue to the relevance of this model is
here in the data showing an association between depression and
acceptance of pain, the opposite process to experiential avoidance.
The findings of this study indicate a need for action. Further
research is required to fill gaps in our understanding of the links
between chronic pain and depression and the ways in which they
combine to impact health and health care use. Such research
may in turn contribute to treatment and health service develop-
ments. There is evidence that psychological treatments for
chronic pain can reduce depression,19,39 in addition to improving
physical functioning. Such treatment could be further developed
and made more available. Of course, the other option is to
develop treatment specifically targeted on depression in this
population. It is not clear which, a depression-specific approach
or a broader psychological approach focused on shared
processes underlying both problems, will produce the more
effective and cost-effective result.
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